NeoGenomics, Inc. recently announced that its PanTracer LBx liquid biopsy test has received Medicare coverage under the MolDX Plasma-Based Genomic Profiling in Solid Tumors policy, allowing eligible ...
Driven Biomarker Discovery, and Expanding Companion Diagnostics Pipelines Fuel Unprecedented Market Expansion.Austin, United States, March 17, 2026 (GLOBE NEWSWIRE) -- Predictive Biomarkers Market ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results